Literature DB >> 9101438

Glucosylceramide metabolism is regulated during normal and hormonally stimulated epidermal barrier development in the rat.

K Hanley1, Y Jiang, W M Holleran, P M Elias, M L Williams, K R Feingold.   

Abstract

Glucosylceramides, delivered to the stratum corneum interstices by exocytosis of lamellar body contents, are enzymatically hydrolyzed to ceramides, which are major components of the lipid lamellar bilayers that mediate epidermal barrier function. Because this conversion is critical for permeability barrier homeostasis in the adult animal, in this study we measured the changes in activities of the enzymes responsible for the synthesis of glucosylceramide and its conversion to ceramide, UDP-glucose:ceramide glucosyltransferase (GC synthase) and beta-glucocerebrosidase (beta-GlcCer'ase), respectively, during fetal barrier formation. In epidermis from rats of gestational age 17-21 days, GC synthase activity peaked on day 19, prior to barrier competence, whereas beta-GlcCer'ase activity rose throughout barrier formation, exhibiting a 5-fold increase over this time period. beta-GlcCer'ase protein rose in parallel with activity, as did mRNA levels. Enzyme activities in skin explants from 17-day fetal rats, incubated up to 4 days in hormone- and serum-free media, paralleled those measured at corresponding time points in utero. Incubation with hormones that accelerate barrier development had minimal effects on GC synthase activity, whereas beta-GlcCer'ase activity was significantly increased after 1 or 2 days in culture. Finally, inhibition of beta-GlcCer'ase with conduritol B epoxide prevented barrier development in vitro and was accompanied by abnormalities in the lamellar bilayer ultrastructure of the stratum corneum. These data indicate that both synthesis and hydrolysis of glucosylceramide are regulated during fetal development. Furthermore, the enzymatic hydrolysis of glucosylceramide to ceramide is essential for fetal barrier ontogenesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9101438

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  7 in total

1.  Mice with type 2 and 3 Gaucher disease point mutations generated by a single insertion mutagenesis procedure.

Authors:  Y Liu; K Suzuki; J D Reed; A Grinberg; H Westphal; A Hoffmann; T Döring; K Sandhoff; R L Proia
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

2.  Activators of the nuclear hormone receptors PPARalpha and FXR accelerate the development of the fetal epidermal permeability barrier.

Authors:  K Hanley; Y Jiang; D Crumrine; N M Bass; R Appel; P M Elias; M L Williams; K R Feingold
Journal:  J Clin Invest       Date:  1997-08-01       Impact factor: 14.808

Review 3.  Hormonal Effects on Asthma, Rhinitis, and Eczema.

Authors:  Natalia Weare-Regales; Sergio E Chiarella; Juan Carlos Cardet; Y S Prakash; Richard F Lockey
Journal:  J Allergy Clin Immunol Pract       Date:  2022-04-15

4.  Acidification in the epidermis and the role of secretory phospholipases.

Authors:  Aegean Chan; Theodora Mauro
Journal:  Dermatoendocrinol       Date:  2011-04-01

5.  Identification of Rice Koji Extract Components that Increase β-Glucocerebrosidase Levels in Human Epidermal Keratinocytes.

Authors:  Kazuhisa Maeda; Yuuka Ogino; Ayano Nakamura; Keiji Nakata; Manabu Kitagawa; Seiki Ito
Journal:  Foods       Date:  2018-06-18

6.  Accelerated Barrier Repair in Human Skin Explants Induced with a Plant-Derived PPAR-α Activating Complex via Cooperative Interactions.

Authors:  George Majewski; John Craw; Timothy Falla
Journal:  Clin Cosmet Investig Dermatol       Date:  2021-09-18

Review 7.  The Roles of Sex Hormones in the Course of Atopic Dermatitis.

Authors:  Naoko Kanda; Toshihiko Hoashi; Hidehisa Saeki
Journal:  Int J Mol Sci       Date:  2019-09-20       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.